Outlook Therapeutics, Inc.
Company Stats
- Market Cap
- $139.6M
- as of Sep 30, 2026
- Shares Outstanding
- 243.4M
- Free Float
- 73.6%
Income Statement
- Revenue
- $1.4M
- Operating Income
- -$67.1M
- Net Income
- -$62.4M
- EBITDA
- -$66.9M
Balance Sheet
- Cash & Equivalents
- $8.1M
Returns & Capital
- SBC, 3Y Avg
- $6.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $1.4M | — | — |
Annual filing data through FY ended September 30, 2025; shares and float as of November 3, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges